论文部分内容阅读
尽管基础医学与临床医学在不断发展,但心力衰竭的病死率及病残率仍然很高。普遍期望早期诊断及早期干预以改观心力衰竭的预后。在过去10年期间,随着心力衰竭的病理生理及分子学机制研究的进展,心脏生物学标志物,特别是脑利钠肽(brainnatriureticpeptide,BNP)受到广泛重视。BNP对成人心力衰竭的诊断、预后的估计及指导治疗等方面的应用已进行很多研究,在儿科的研究也在逐步增多。小儿与成人,不
Despite the continuous development of basic medicine and clinical medicine, the mortality and morbidity of heart failure are still high. It is widely expected that early diagnosis and early intervention will improve the prognosis of heart failure. Over the past 10 years, along with the progress of the pathophysiology and molecular mechanisms of heart failure, cardiac biomarkers, especially brain natriuretic peptide (BNP), have attracted much attention. BNP on the diagnosis of adult heart failure, prognosis and guidance to guide the application of treatment has been a lot of research, research in pediatrics is also gradually increased. Pediatric and adult, no